What is the management of anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Anaphylaxis

Immediately administer intramuscular epinephrine 0.01 mg/kg (maximum 0.3 mg in prepubertal children, 0.5 mg in adults) into the mid-outer thigh as soon as anaphylaxis is recognized—this is the only first-line treatment and delays in administration are associated with fatality. 1, 2

Immediate First-Line Treatment

Epinephrine is the cornerstone of anaphylaxis management and must never be delayed or substituted with antihistamines or bronchodilators. 1, 3

Epinephrine Administration

  • Administer intramuscular epinephrine 0.01 mg/kg using 1:1000 concentration in the anterolateral thigh (maximum 0.3 mg in prepubertal children, 0.5 mg in adults) 4, 1, 2
  • For children, use epinephrine auto-injector 0.15 mg if weight is 10-25 kg or 0.3 mg if ≥25 kg 1
  • The intramuscular route in the lateral thigh is superior to other routes because it provides rapid absorption and higher epinephrine levels 5
  • Repeat epinephrine every 5-15 minutes if symptoms persist or progress—there are no absolute contraindications to epinephrine in anaphylaxis 4, 1, 2

Immediate Supportive Measures

  • Call emergency services (911/EMS) immediately 1
  • Position patient supine with elevated lower extremities to prevent orthostatic hypotension and improve circulation to vital organs 4, 1
  • If respiratory distress or vomiting is present, position patient for comfort 1
  • Establish intravenous access and administer oxygen 6, 2

Subsequent Emergency Care (After Epinephrine)

Fluid Resuscitation

  • Administer normal saline rapidly for volume replacement: 1-2 L in adults at 5-10 mL/kg in first 5 minutes; up to 30 mL/kg in first hour for children 4
  • For graded responses: 500 mL for Grade II reactions, 1 L for Grade III reactions, escalating to 20-30 mL/kg for refractory cases 6, 2
  • Up to 7 L of crystalloid may be necessary due to increased vascular permeability that can transfer 50% of intravascular fluid to extravascular space within 10 minutes 4

Airway Management

  • Maintain airway patency—consider endotracheal intubation or cricothyroidotomy if laryngeal edema is severe and clinicians are adequately trained 4
  • Administer supplemental oxygen, especially for prolonged reactions, pre-existing hypoxemia, or patients requiring multiple epinephrine doses 4

Second-Line Adjunctive Therapies (Never as Monotherapy)

Antihistamines

  • Administer H1-antihistamine diphenhydramine 1-2 mg/kg or 25-50 mg parenterally only after epinephrine 4, 6, 2
  • Consider H2-antihistamine ranitidine 50 mg IV in adults (1 mg/kg in children) diluted in 5% dextrose over 5 minutes 4, 6, 2
  • The combination of H1 and H2 antihistamines is superior to H1 alone, but both have much slower onset than epinephrine 4

Bronchodilators

  • For bronchospasm resistant to adequate epinephrine doses: administer nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as necessary 4, 2

Corticosteroids

  • Consider systemic corticosteroids for patients with history of idiopathic anaphylaxis, asthma, or severe/prolonged anaphylaxis 4, 6
  • Administer IV methylprednisolone equivalent 1.0-2.0 mg/kg/day every 6 hours, or oral prednisone 0.5 mg/kg for less critical episodes 4
  • Corticosteroids are not helpful acutely but may prevent biphasic or protracted reactions 4, 2

Management of Refractory Anaphylaxis

Escalating Epinephrine

  • If inadequate response after 10 minutes, double the epinephrine bolus dose 6
  • Consider epinephrine infusion (0.05-0.1 μg/kg/min) when more than three boluses have been administered 6, 2
  • Prepare infusion by adding 1 mg (1 mL) of 1:1000 epinephrine to 250 mL D5W (concentration 4.0 μg/mL), infuse at 1-4 μg/min, increasing to maximum 10 μg/min 4

Additional Vasopressors

  • For hypotension refractory to epinephrine and fluids: add norepinephrine infusion (0.05-0.5 μg/kg/min) or dopamine 2-20 μg/kg/min titrated to maintain systolic BP >90 mmHg 4, 6, 2
  • Consider vasopressin 1-2 IU bolus with or without infusion (2 units/h) for persistent hypotension 6

Special Considerations

  • For patients on beta-blockers with refractory symptoms: administer IV glucagon 1-5 mg (20-30 μg/kg in children, maximum 1 mg) over 5 minutes, followed by infusion 5-15 μg/min 4, 6
  • Glucagon bypasses beta-receptor blockade and has positive inotropic and chronotropic effects 4

Cardiopulmonary Arrest During Anaphylaxis

  • Initiate CPR and advanced cardiac life support immediately 4, 2
  • Administer high-dose IV epinephrine rapidly: 1-3 mg (1:10,000 dilution) over 3 minutes, then 3-5 mg over 3 minutes, followed by 4-10 μg/min infusion 4
  • For children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution, maximum 0.3 mg) every 3-5 minutes 4
  • Consider higher doses (0.1-0.2 mg/kg of 1:1000 solution) for unresponsive asystole or pulseless electrical activity 4
  • Administer atropine and consider transcutaneous pacing for asystole/pulseless electrical activity 4
  • Prolonged resuscitation efforts are encouraged—outcomes are better in anaphylaxis than other causes of arrest because patients are typically young with healthy cardiovascular systems 4

Critical Pitfalls to Avoid

  • Never delay epinephrine administration—delayed injection is the primary factor associated with fatality 1, 3
  • Never substitute antihistamines, corticosteroids, or bronchodilators for epinephrine—these are adjunctive only 1, 6, 2
  • Never administer IV epinephrine in non-arrest situations without continuous hemodynamic monitoring due to risk of lethal arrhythmias 4
  • IV epinephrine should only be used during cardiac arrest or in profoundly hypotensive patients who fail to respond to IM epinephrine and volume replacement 4, 2

Observation and Monitoring

  • Observe all patients for minimum 6 hours in a monitored setting, as there are no reliable predictors of biphasic reactions 4, 1, 6
  • Biphasic reactions (recurrence without re-exposure) can occur in up to 20% of cases 1
  • Obtain serum tryptase levels if diagnosis is unclear: first sample at 1 hour, second at 2-4 hours, baseline at least 24 hours post-reaction 6

Post-Event Management

  • Provide patient with two epinephrine auto-injectors and comprehensive training on self-administration 4, 1
  • Provide written anaphylaxis emergency action plan detailing symptom recognition and treatment steps 1
  • Refer all patients to an allergist-immunologist for diagnostic evaluation, identification of triggers, and long-term management 4, 1
  • Consider medical identification jewelry 1

References

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anafilaxia Manejo y Tratamiento

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of epinephrine in the treatment of anaphylaxis.

Current opinion in allergy and clinical immunology, 2003

Guideline

Anaphylaxis Management in Sugammadex-Induced Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.